Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,804 total articles
Upstart’s pivot to a national bank charter changes the playbook: deposit-taking and direct lending could materially expand margins and revenue streams. Valuation is reasonable relative to the upside, technicals show near-term exhaustion, and catalysts over the next 6 months can re-rate the stock. This is a tactical long with a defined stop and a 18…
Amazon ($AMZN) shows tangible near-term technical pressure with bearish momentum indicators and moving averages sloping down; that creates an actionable short opportunity over the next 10 trading days. Fundamentals remain robust - a $2.18T market cap, EPS of $7.24, ROE ~18.9%, and high-margin AWS and advertising growth - supporting a longer-term ac…
Celsius (CELH) has been clubbed over the last month: price is trading near $34, RSI ~28 and the stock sits 49% off its 52-week high as investors digest private-label competition and aggressive M&A. Fundamentals still show scale — market cap ~$8.84B, trailing P/E in the 130s-140s, EV/EBITDA ~18 and free cash flow of $323m — which supports a tactical…
Clear Secure (YOU) is entering a new phase: membership scale, enterprise identity wins and a step-up in free cash flow make the stock a buy here. We upgrade the rating and lay out an actionable trade with a clear entry at $49.51, a $41.00 stop and a $70.00 target over a multi-month horizon.
Ciena has rallied on AI data-center demand and conference-driven order flow, but a fast pullback to $373 creates a measured entry. The trade: buy on weakness at $375, stop at $345, target $460 for a mid-term (45 trading days) swing. Thesis rests on strong revenue growth, a multi-billion dollar backlog and durable secular demand for optical intercon…
Visa is trading near key technical support after a pullback; fundamentals remain solid (EPS $8.80, FCF $22.9B, ROE 43.6%) and analysts expect double-digit EPS growth to continue. This is a mid-term swing trade: enter $298.00, stop $290.00, target $335.00 over ~45 trading days.
Visteon is trading like a cyclical auto-parts name while quietly compounding software and cockpit wins. At ~$86.62 the stock offers an attractive EV/EBITDA and free-cash-flow yield against a growing TAM for connected, AI-enabled cockpits. This is a tactical long for traders looking to own exposure to automotive software/vision upside with a tight s…
<p>Ormat Technologies (ORA) has pulled back from its February highs and now trades near $111, offering a cleaner risk-reward for long-term investors. With $989.5M of 2025 revenue, accelerating energy storage and product segment performance, and multi-decade PPAs that add long-duration cash flow visibility, ORA looks like a buyable dip for investors…
Aptiv (APTV) looks like a buyable swing setup: the stock is down from its 52-week high, technicals show short-term oversold, and the business generates meaningful free cash flow. Valuation metrics - EV/EBITDA ~6.7 and price-to-sales ~0.7 - suggest upside if OEM production normalizes and software-defined vehicle spending continues. The trade plan ta…
Palantir is shifting from analytics vendor to the embedded decision layer for government and commercial operators. Recent wins - including Maven's program-of-record designation and multiple large-system integrations - increase switching costs and create a clearer pathway to multi-year contract waterfalls. Valuation is rich, but the market pullback …
Intel’s transition into AI-centric CPUs and a cheaper, more diversified revenue mix is underpriced by the market. Recent product launches, partnerships, and industry-wide CPU price increases give Intel a clear catalyst runway. This is a mid-term swing trade that buys the narrative at the current base, with a defined stop to protect against executio…
Northrop Grumman ($NOC) trades below obvious re-rating levels for a defense prime with strong free cash flow, improving backlog exposure to space and integrated battle command systems, and a manageable balance sheet. With an enterprise value near $107.1B and free cash flow roughly $3.3B, I see a mid-term trade to capture program execution upside as…
Inspired Entertainment (INSE) offers an asymmetric setup: entrenched gaming and virtual-sports products, recent technical support and upbeat momentum, and a sub-$1x price-to-sales multiple that leaves upside if Strata and interactive revenues accelerate. We layout an actionable mid-term trade with precise entry, stop and target.
Intel is positioned to capture a material slice of renewed CPU-led AI demand while launching competitively priced workstation GPUs and expanding foundry services. At $43.49 and a market cap near $217B, the stock offers asymmetric upside if AI-driven pricing power and product wins translate to positive cash flow. This is a conviction swing trade: en…
Porch Group (PRCH) is trading well below its 52-week high after a pullback. With a $717M market cap, $52M in trailing free cash flow, and improving top-line momentum after recent beats, a targeted long into a Texas expansion narrative offers asymmetric upside over the next 180 trading days. This trade idea lays out entry, stop and a two-stage targe…
Coinbase is trading near $166 after a painful multi-quarter drawdown, but recent product wins - notably the Fannie Mae-backed crypto mortgage pilot and continued growth in onchain product revenue - materially change the company's optionality. We upgrade to a buy and lay out a long-term trade (180 trading days) with a clear entry at $166.05, a stop …
Q32 Bio's small-cap rerating since the ADX-097 asset sale has left bempikibart as the focal point for upside. With a market cap near $107M, low float, positive technicals and clear upcoming catalysts, a mid-term long trade offers asymmetric upside if clinical announcements remain constructive. Tight risk management is essential given binary clinica…
Celsius (CELH) has pulled back sharply into oversold territory even as 2025 revenue surged to a record $2.5 billion and strategic acquisitions (Alani Nu, Rockstar) materially accelerate growth. The pullback after competitor noise (Costco private label) presents a trade-able long: enter near $34.86, stop $30.00, target $52.00 on a 180-trading-day ho…
Novo Nordisk (NVO) has pulled back from 2025 highs and now trades near its 52-week low after a period of heavy multiple compression. The FDA approval of Awiqli (weekly basal insulin) on 03/27/2026 is a substantial fundamental catalyst that can reaccelerate growth and offset headline risk. With a market cap of $162.7B, a P/E of 10.34 and a dividend …
Coeur Mining (CDE) has retraced sharply despite stronger cash flow, a manageable balance sheet and a meaningful production boost from the New Gold acquisition. A tactical long at $17.50 with a $15.90 stop targets $22.00 over the next ~45 trading days, playing for a recovery to the 50-day technical band and re-rating driven by buybacks, dividend ini…
Aptiv trades at an attractive enterprise-value-to-sales and EV/EBITDA multiple while sitting squarely in markets (ADAS, VCUs, vehicle electrification, software-defined vehicles) growing at double-digit rates. Technicals show oversold momentum and short interest is manageable. This trade plan buys the current weakness with a clear stop and a 180-tra…
PROCEPT BioRobotics (PRCT) is a commercial-stage surgical robotics company focused on Aquablation for BPH. The stock trades at $26.49 with a $1.49B market cap after a February guidance cut and a subsequent wave of negative headlines. Fundamentals show rapid prior top-line growth, a strong liquidity position, and an EV/sales ratio that can compress …
Samsara just proved it can grow into profitability while moving deeper into large-enterprise accounts. With $1.89B ARR, accelerating $100K+ customer mix, and two consecutive GAAP profitable quarters, the company is trading at an attractive risk/reward for a long trade. Entry $30.00, target $42.00, stop $26.00 — long term (180 trading days).
Monarch Cement (MCEM) has already delivered a nice run from its 2025 low, but the company’s sub-$1B market cap, modest PE of 14.3, and concrete exposure to U.S. infrastructure spending leave a constructive setup. The trade is long with defined risk - target near the 52-week high and a stop below structurally important support. Liquidity is low and …
Alphabet's recent model-quantization work is often read as reducing hardware needs. That's a surface-level take. TurboQuant lowers per-inference cost, which accelerates adoption and utilization of large models in production — a dynamic that increases demand for high-bandwidth memory and premium SSDs. Micron has mass-produced HBM4, posted blockbuste…
